Fluorescent dyes are commonly used as hydrologic tracers in a variety of surface and subsurface environments, including karst aquifers and caves, but the fragile nature of karstic groundwater ecosystems suggests a cautious approach to selecting dyes. This study tested the effects of four fluorescent dye tracers (uranine, eosin, pyranine, sulforhodamine B) on microorganisms from Fort Stanton Cave, New Mexico, United States. Toxicity of the dyes was tested on bacteria isolated from the cave and on a sediment sample collected adjacent to Snowy River in Fort Stanton Cave. The isolates showed minimal inhibition by the four dyes in an agar diffusions assay. Minimum inhibitory concentrations calculated from liquid culture assays of one isolate were 35 g/L for uranine, 3.5 g/L for eosin, 0.1 g/L for pyranine, and 10 mg/L for sulforhodamine B. A C-glucose radiotracer experiment showed zero inhibition of overall microbial activity in a sediment sample at all dye concentrations, except at 350 g/L eosin. Thus, there are no cave-specific findings to indicate that Fort Stanton's microbes are especially sensitive to these commonly used dyes. Moreover, a literature survey of mutagenicity tests on these dyes indicates they are safe for environmental use. These results corroborate previous dye toxicity tests and suggest that these four dyes are suitable for use at Fort Stanton Cave in the concentration ranges commonly used for groundwater tracing. While broader testing of dyes with microbes from other caves is advised, the results suggest the dyes may be safe for all karst aquifers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/gwat.13160 | DOI Listing |
J Gen Intern Med
October 2024
Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA.
Background: Direct-acting oral anticoagulants (DOACs) are recommended to reduce risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). However, DOAC dosing inconsistent with FDA-approved product labels is common and associated with poor clinical outcomes.
Objectives: Identify DOAC dosing inconsistent with FDA-approved product labels in ambulatory care patients with NVAF; identify variables associated with dosing lower and higher than label.
Front Physiol
April 2024
Department of Surgery, Duke University Medical Center, Durham, NC, United States.
It may take decades to develop cardiovascular dysfunction following exposure to high doses of ionizing radiation from medical therapy or from nuclear accidents. Since astronauts may be exposed continually to a complex space radiation environment unlike that experienced on Earth, it is unresolved whether there is a risk to cardiovascular health during long-term space exploration missions. Previously, we have described that mice exposed to a single dose of simplified Galactic Cosmic Ray (GCR) develop cardiovascular dysfunction by 12 months post-radiation.
View Article and Find Full Text PDFJ Extracell Vesicles
February 2024
Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mil Med
May 2024
ImmunoVation, Stanton, CA 90680, USA.
Introduction: Preeclampsia (PE), a hypertensive-inflammatory disorder of pregnancy, poses acute risks of seizures, stroke, and heart attack during pregnancy and up to 6 weeks post-delivery. Recent data suggest that residual increased risks for cardiovascular disease (CVD) linger for much longer, possibly decades, after PE pregnancies. In civilian studies, PE and the major vascular events resulting from it disproportionately affect women from minority groups, especially African American women.
View Article and Find Full Text PDFJ Assoc Nurses AIDS Care
June 2023
Jessica L. Elf, PhD, MPH, is an Assistant Professor, Colorado State University, Fort Collins, Colorado, USA. Kimberly Horn, EdD, is a Research Professor, Virginia Tech, Roanoke, Virginia, USA. Lorien Abroms, ScD, MA, is a Professor, George Washington University, Washington, District of Columbia, USA. Cassandra A. Stanton, PhD, is a Senior Epidemiologist, Westat, Rockville, Maryland, USA. Amy M. Cohn, PhD, is an Associate Professor, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Freya Spielberg, MD, MPH, is an Associate Professor, University of Texas at Austin, Austin, Texas, USA. Tiffany Gray, DrPh, MPH, is Adjunct Faculty at George Washington University, Washington, District of Columbia, USA and Public Health Analyst at the D.C. Department of Health, Washington, District of Columbia, USA. Emily Harvey, MPH, is a Manager of Primary Research, Bain & Company, New York, New York, USA. Charles Debnam, BA, is Deputy Chief Executive Officer, Community Wellness Alliance, Washington, District of Columbia, USA. Lexi Kierstead, MPH, is a Research Associate, Truth Initiative, Washington, District of Columbia, USA. Matthew E. Levy, PhD, is a Research Scientist, George Washington University, Washington, District of Columbia, USA. Amanda Castel, MD, MPH, is a Professor, George Washington University, Washington, District of Columbia, USA. Anne Monroe, MD, MSPH, is an Associate Professor, George Washington University, Washington, District of Columbia, USA. Raymond Niaura, PhD, is a Professor, New York University, New York, New York, USA.
Using data from the D.C. Cohort Longitudinal HIV Study, we examined (a) diagnosed mental health and (b) cardiovascular, pulmonary, or cancer (CPC) comorbidity among adults with HIV who smoked.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!